Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06798584 · ClinicalTrials.gov registry record · NA
How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?
A NA study, sponsored by Purdue University.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06798584 is a NA study that has not yet begun recruiting, run by Purdue University. The registered enrollment target is 240 participants.
The verdict
NCT06798584, a NA study, has not yet begun recruiting, sponsored by Purdue University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? * How does iron repletion, via supplementation, affect cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? The investigators will compare the effect of iron supplements to a placebo (gelatin capsule) to see if iron supplements could improve iron status, cognitive function, mood, quality of family relationships, and quality of life of iron-deficient and/or anemic women undergoing the menopausal transition. Each participant will: * Make 2 visits (about 2 hours each - baseline and endline) to the Clinical Research Center at Purdue * Make a very brief visit at midpoint (about 10 minutes) for a checkup * Take a daily study supplement or placebo for 4 months
Interventions
- DIETARY_SUPPLEMENT FeoSol Original Iron Supplement Tablets
- DIETARY_SUPPLEMENT 21st Century Gelatin Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06798584
The ClinicalTrials.gov registry entry for NCT06798584 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FeoSol Original Iron Supplement Tablets is the first listed.
NCT06798584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06798584 about?
NCT06798584 is a clinical study titled "How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?". The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of ...
What is the current status of trial NCT06798584?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-03-01. Estimated completion is 2025-12.
What interventions are being tested in trial NCT06798584?
The interventions under investigation include: FeoSol Original Iron Supplement Tablets (DIETARY_SUPPLEMENT), 21st Century Gelatin Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06798584?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.